Tamoxifen in the Mouse Brain: Implications for Fate-Mapping Studies Using the Tamoxifen-Inducible Cre-loxP System
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Variability in Tam metabolism and clearance have been reported based on age, dosage, treatment duration, genetic differences, sex, and other factors, leading to different half-lives and potencies of the metabolites.19,20,21”
From Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age (2023) · cites this paper as [19]
In the citing paper
“Tam is metabolized by cytochrome P450 into the metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen, endoxifen, and norendoxifen, with 4-hydroxytamoxifen being the most potent metabolite.18,19”
From Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age (2023) · cites this paper as [19]
In the citing paper
“Studies have identified some difference in Tam metabolism with age, sex, and other factors,19 and a few studies have described limitations and acute negative effects of Tam induction in embryonic and early postnatal models.23,65”
From Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age (2023) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kang, S. H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D. W., Ostrow, L. W., Rothstein, J. D., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3357 · Cited by 599
The metabolic footprint of aging in mice
Houtkooper, R. H., Argmann, C., Houten, S. M., Cantó, C., Jeninga, E. H., Andreux, P. A., Thomas, C., Doenlen, R., Schoonjans, K., & Auwerx, J. (2011) · Scientific Reports · doi:10.1038/srep00134 · Cited by 528
Age-dependent fate and lineage restriction of single NG2 cells
Zhu, X., Hill, R. A., Dietrich, D., Komitova, M., Suzuki, R., & Nishiyama, A. (2011) · Development · doi:10.1242/dev.047951 · Cited by 464 · cited 1×
“We first tested the efficacy of tamoxifen and its metabolites in our Cre-loxP system – Cspg4/tomato mice – in vitro, and subsequently we determined the effective brain concentration of the most potent metabolite 4-hydroxytamoxifen, and degradation kinetics of tamoxifen and its metabolites in vivo.”
MethodProtective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4
Benner, E. J., Luciano, D., Jo, R., Abdi, K., Paez-Gonzalez, P., Sheng, H., Warner, D. S., Liu, C., Eroglu, C., & Kuo, C. T. (2013) · Nature · doi:10.1038/nature12069 · Cited by 282
Clarke, L. E., Young, K. M., Hamilton, N. B., Li, H., Richardson, W. D., & Attwell, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0928-12.2012 · Cited by 182
Research works printed but not linked: 24
- Berglund, 2008, Glucose metabolism in vivo in four commonly used inbred mouse strains., Diabetes Metab. Res. Rev., 57, 1790, 10.2337/db07-1615 · DOI · Paper page
- Coumoul, 2003, Roles of FGF receptors in mammalian development and congenital diseases., Birth Defects Res. C Embryo Today, 69, 286, 10.1002/bdrc.10025 · DOI
- De Biase, 2011, NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination., J. Neurosci., 31, 12650, 10.1523/JNEUROSCI.2455-11.2011 · DOI · Paper page
- Deng, 2002, Tumor formation in Brca1 conditional mutant mice., Environ. Mol. Mutagen., 39, 171, 10.1002/em.10069 · DOI
- Desta, 2004, Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6., J. Pharmacol. Exp. Ther., 310, 1062, 10.1124/jpet.104.065607 · DOI · Paper page
- Friedberg, 2006, Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7., DNA Repair (Amst.), 5, 189, 10.1016/j.dnarep.2005.09.009 · DOI
- Hayashi, 2002, Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse., Dev. Biol., 244, 305, 10.1006/dbio.2002.0597 · DOI · Paper page
- Honsa, 2013, Focal cerebral ischemia induces the neurogenic potential of mouse Dach1-expressing cells in the dorsal part of the lateral ventricles., Neuroscience, 240, 39, 10.1016/j.neuroscience.2013.02.048 · doi:10.1016/j.neuroscience.2013.02.048
- Iusuf, 2011, P-glycoprotein (ABCB1) transports the primary active tamoxifen metabolites endoxifen and 4-hydroxytamoxifen and restricts their brain penetration., J. Pharmacol. Exp. Ther., 337, 710, 10.1124/jpet.110.178301 · DOI
- Jordan, 2007, New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer., Steroids, 72, 829, 10.1016/j.steroids.2007.07.009 · DOI · Paper page
- Kang, 2010, NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration., Neuron, 68, 668, 10.1016/j.neuron.2010.09.009 · DOI · Paper page
- Katzenellenbogen, 1984, Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 human breast cancer cells bioactivities, estrogen receptor interactions, and plasminogen tamoxifen isomers., Cancer Res., 44, 112
- Komitova, 2011, NG2 cells are not a major source of reactive astrocytes after neocortical stab wound injury., Glia, 59, 800, 10.1002/glia.21152 · DOI
- Le, 2000, Conditional gene knockout using cre recombinase., Methods Mol. Biol., 136, 477, 10.1385/1-59259-065-9:477 · DOI
- Leone, 2003, Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells., Mol. Cell. Neurosci., 22, 430, 10.1016/S1044-7431(03)00029-0 · DOI · Paper page
- Li, 2010, Focal cerebral ischemia induces a multilineage cytogenic response from adult subventricular zone that is predominantly gliogenic., Glia, 58, 1610, 10.1002/glia.21033 · DOI · Paper page
- Lien, 1991, Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment., Cancer Res., 51, 4837
- Lim, 2005, Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen., Cancer Chemother. Pharmacol., 55, 471, 10.1007/s00280-004-0926-7 · DOI · Paper page
- Lu, 2012, The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents., Breast Cancer Res. Treat., 133, 99, 10.1007/s10549-011-1699-4 · DOI
- Robins, 2013, Evidence for NG2-glia derived, adult-born functional neurons in the hypothalamus., PLoS ONE, 8, 10.1371/journal.pone.0078236 · DOI
- Teunissen, 2011, Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 879, 1677, 10.1016/j.jchromb.2011.04.011 · doi:10.1016/j.jchromb.2011.04.011
- Vaillant, 2014, Mouse strain differences in metabolic fluxes and function of ex vivo working hearts., Am. J. Physiol. Heart Circ. Physiol., 306, H78, 10.1152/ajpheart.00465.2013 · DOI
- Weinstein, 2000, Functions of mammalian Smad genes as revealed by targeted gene disruption in mice., Cytokine Growth Factor Rev., 11, 49, 10.1016/S1359-6101(99)00028-3 · DOI · Paper page
- Yan, 2015, Evolution of blood-brain barrier damage associated with changes in brain metabolites following acute ischemia., Neuroreport, 26, 945, 10.1097/WNR.0000000000000438 · DOI
Cited by
Hernandez, V. G., Lechtenberg, K. J., Peterson, T. C., Zhu, L., Lucas, T. A., Bradshaw, K. P., Owah, J. O., Dorsey, A. I., Gentles, A. J., & Buckwalter, M. S. (2023) · Glia · doi:10.1002/glia.24377 · Cited by 51
Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions.
Dias, D. O., Kalkitsas, J., Kelahmetoglu, Y., Estrada, C. P., Tatarishvili, J., Ernst, A., Huttner, H. B., Kokaia, Z., Lindvall, O., Brundin, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.30.068965
Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age
Kellogg, C. M., Pham, K., Ko, S., Cox, J. E. J., Machalinski, A. H., Stout, M. B., Sharpe, A. L., Beckstead, M. J., Chucair-Elliott, A. J., Ocañas, S. R., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108413 · Cited by 10
Metadata
- Authors
- Valny, M., Honsa, P., Kirdajova, D., Kamenik, Z., & Anderova, M.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2016-10-20
- Volume
- 10
- ISSN
- 1662-5102
- Cited by
- 79
- References
- 5
- Funders
- Grantová Agentura České Republiky (GACR 16-10214S, GACR 15-02760S)
- Grantová Agentura, Univerzita Karlova (GA UK: 134615)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.